Background/Objectives: Listeria monocytogenes is a foodborne pathogen of major public health concern due to its ability to invade host cells and cause severe illness. This study aimed to develop and validate a multi-tiered screening pipeline to identify Bacillus strains with probiotic potential against L. monocytogenes. Methods: A total of 26 Bacillus isolates were screened for antimicrobial activity, gastrointestinal resilience, and host cell adhesion. A fluorescence-based infection assay using mCherry-expressing HCT 116 cells was used to assess cytoprotection against L. monocytogenes NCTC 7973. Eight strains significantly improved host cell viability and were validated by quantification of intracellular CFU. Two top candidates were tested in a murine model of listeriosis. The genome of the lead strain was sequenced to evaluate safety and biosynthetic potential. Results: B. subtilis CECT 8266 completely inhibited intracellular replication of L. monocytogenes in HCT 116 cells, reducing bacterial recovery to undetectable levels. In vivo, it decreased splenic bacterial burden by approximately 6-fold. Genomic analysis revealed eight bacteriocin biosynthetic clusters and silent antibiotic resistance genes within predicted genomic islands, as determined by CARD and Alien Hunter analysis. The strain also demonstrated bile and acid tolerance, as well as strong adhesion to epithelial cells. Conclusions: The proposed pipeline enables efficient identification of probiotic Bacillus strains with intracellular protective activity. B. subtilis CECT 8266 is a promising candidate for translational applications in food safety or health due to its efficacy, resilience, and safety profile.
The human tissue–resident T cell pool consists of a diverse array of conventional adaptive as well as unconventional invariant T cells that populate barrier sites and carefully balance immune defense in the context of microbial exposure. Here, we investigated the tissue-resident CD4 T cell compartment across donor-matched lymphoid and nonlymphoid tissues and uncovered a population enriched primarily in the ileum and liver displaying a rich polyfunctional profile with diverse T helper 1/17/22 characteristics. These CD4 T cells were highly responsive, susceptible to innate cytokine–driven activation, and identified by CD161 and CD56 coexpression. Their transcriptional and protein expression profile included innate-like effector features including NKp80, NKG2D, NKG7, as well as granzyme K, and exhibited characteristics of tissue residence, persistence, and barrier repair, and they were depleted in the colon of patients with inflammatory bowel disease. Notably, the CD161 + CD56 + CD4 T cell pool was expanded in cytomegalovirus (CMV)–seropositive individuals and enriched in CMV-specific T cell receptors and responses. Together, we identify a potent effector-memory CD4 T cell subset resident in the gastrointestinal tract and liver, defined by enhanced innateness and enriched in CMV-specificity.